Fresenius SE Operating Margin 2016-2023 | FSNUY

Current and historical operating margin for Fresenius SE (FSNUY) over the last 10 years. The current operating profit margin for Fresenius SE as of September 30, 2023 is 4.23%.
Fresenius SE Operating Margin Historical Data
Date TTM Revenue TTM Operating Income Operating Margin
2023-09-30 $39.20B $2.51B 6.40%
2023-06-30 $43.73B $3.02B 6.92%
2023-03-31 $43.10B $3.33B 7.73%
2022-12-31 $43.03B $3.50B 8.13%
2022-09-30 $43.53B $4.09B 9.40%
2022-06-30 $43.99B $4.39B 9.98%
2022-03-31 $44.47B $4.72B 10.61%
2021-12-31 $44.39B $4.92B 11.08%
2021-09-30 $44.08B $4.86B 11.03%
2021-06-30 $43.51B $4.97B 11.43%
2021-03-31 $42.19B $4.98B 11.81%
2020-12-31 $41.44B $5.01B 12.09%
2020-09-30 $40.66B $5.19B 12.76%
2020-06-30 $40.06B $5.14B 12.83%
2020-03-31 $40.09B $5.16B 12.87%
2019-12-31 $39.66B $5.19B 13.08%
2019-09-30 $39.42B $5.18B 13.13%
2019-06-30 $39.12B $5.13B 13.12%
2019-03-31 $39.27B $6.19B 15.77%
2018-12-31 $39.60B $6.20B 15.66%
2018-09-30 $39.76B $6.10B 15.34%
2018-06-30 $39.98B $6.20B 15.50%
2018-03-31 $39.37B $5.16B 13.12%
2017-12-31 $38.30B $5.19B 13.54%
2017-09-30 $36.47B $5.24B 14.35%
2017-06-30 $34.84B $5.12B 14.70%
2017-03-31 $33.47B $5.03B 15.02%
2016-12-31 $32.18B $4.79B 14.88%
2016-09-30 $31.71B $11.39B 35.93%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $17.783B $24.011B
Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies essential drugs, clinical nutrition products, medical devices and services and Fresenius Vamed plans, develops and manages healthcare facilities. Fresenius SE & Co is headquartered in Bad Homburg, Germany.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $15.314B 15.83
DaVita (DVA) United States $12.380B 15.38
Elanco Animal Health (ELAN) United States $8.910B 23.12
Encompass Health (EHC) United States $8.488B 21.73
Chemed (CHE) United States $8.156B 25.28
Option Care Health (OPCH) United States $4.844B 18.34
RadNet (RDNT) United States $4.320B 89.95
Amedisys (AMED) United States $3.000B 21.25
Astrana Health (ASTH) United States $2.212B 29.92
LifeStance Health (LFST) United States $2.018B 0.00
Addus HomeCare (ADUS) United States $1.906B 27.27
U.S Physical Therapy (USPH) United States $1.423B 38.09
Pennant (PNTG) United States $0.682B 36.05
Aveanna Healthcare Holdings (AVAH) United States $0.477B 0.00
Atai Life Sciences (ATAI) Germany $0.229B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Novo Integrated Sciences (NVOS) United States $0.017B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00